Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.

Murtola TJ, Tammela TL, Lahtela J, Auvinen A.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2226-32.

2.

Epidemiologic musing on statin drugs in the prevention of advanced prostate cancer.

Platz EA.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2175-80. Epub 2007 Nov 2. No abstract available.

3.

Statin use and risk of prostate cancer in the California Men's Health Study cohort.

Flick ED, Habel LA, Chan KA, Van Den Eeden SK, Quinn VP, Haque R, Orav EJ, Seeger JD, Sadler MC, Quesenberry CP Jr, Sternfeld B, Jacobsen SJ, Whitmer RA, Caan BJ.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2218-25. Epub 2007 Oct 30.

4.

Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort.

Jacobs EJ, Rodriguez C, Bain EB, Wang Y, Thun MJ, Calle EE.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2213-7. Epub 2007 Oct 30.

5.

Long-term follow-up of the West of Scotland Coronary Prevention Study.

Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM; West of Scotland Coronary Prevention Study Group.

N Engl J Med. 2007 Oct 11;357(15):1477-86.

6.

Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients.

Bonovas S, Filioussi K, Flordellis CS, Sitaras NM.

J Clin Oncol. 2007 Aug 10;25(23):3462-8.

7.

Statin use and breast cancer risk in a large population-based setting.

Boudreau DM, Yu O, Miglioretti DL, Buist DS, Heckbert SR, Daling JR.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):416-21.

8.

Statin use and the risk of 10 cancers.

Coogan PF, Rosenberg L, Strom BL.

Epidemiology. 2007 Mar;18(2):213-9.

PMID:
17235211
9.

Statin drugs and risk of advanced prostate cancer.

Platz EA, Leitzmann MF, Visvanathan K, Rimm EB, Stampfer MJ, Willett WC, Giovannucci E.

J Natl Cancer Inst. 2006 Dec 20;98(24):1819-25.

10.

Statins and risk of cancer: a systematic review and metaanalysis.

Browning DR, Martin RM.

Int J Cancer. 2007 Feb 15;120(4):833-43. Review.

11.

Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.

Bonovas S, Filioussi K, Tsavaris N, Sitaras NM.

J Clin Oncol. 2006 Oct 20;24(30):4808-17. Epub 2006 Sep 25.

12.
13.

Statins, especially atorvastatin, may improve survival following brachytherapy for clinically localized prostate cancer.

Moyad MA, Merrick GS, Butler WM, Wallner KE, Galbreath RW, Butler EG, Allen ZA, Adamovich E.

Urol Nurs. 2006 Aug;26(4):298-303.

PMID:
16939047
14.

Statin use and breast cancer: prospective results from the Women's Health Initiative.

Cauley JA, McTiernan A, Rodabough RJ, LaCroix A, Bauer DC, Margolis KL, Paskett ED, Vitolins MZ, Furberg CD, Chlebowski RT; Women's Health Initiative Research Group.

J Natl Cancer Inst. 2006 May 17;98(10):700-7.

15.

Do statins protect against prostate cancer?

Goldstraw MA, Amoroso P, Kirby RS.

BJU Int. 2006 Jun;97(6):1147-8. No abstract available.

16.

Statins and breast cancer prevention: time for randomized controlled trials.

Sprague JR, Wood ME.

J Clin Oncol. 2006 May 1;24(13):2129-30; author reply 2130-1. No abstract available.

17.

Statins and cancer risk: a meta-analysis.

Dale KM, Coleman CI, Henyan NN, Kluger J, White CM.

JAMA. 2006 Jan 4;295(1):74-80.

PMID:
16391219
18.
19.

Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.

Bonovas S, Filioussi K, Tsavaris N, Sitaras NM.

J Clin Oncol. 2005 Dec 1;23(34):8606-12. Epub 2005 Oct 31.

20.

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators.

Lancet. 2005 Oct 8;366(9493):1267-78. Epub 2005 Sep 27. Erratum in: Lancet. 2005 Oct 15-21;366(9494):1358. Lancet. 2008 Jun 21;371(9630):2084.

PMID:
16214597
Items per page

Supplemental Content

Write to the Help Desk